Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hyaluronic acid + ketorolac is a combination therapy investigated by Mahidol University for the treatment of adhesive capsulitis (frozen shoulder). The treatment involves a single intra-articular injection containing moderate-molecular-weight hyaluronic acid, which provides mechanical lubrication (viscosupplementation) and biological signaling through CD44 receptors, and ketorolac, a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes to reduce local inflammation and pain. In clinical trials, the formulation often included lidocaine as a local anesthetic. This combination aims to improve shoulder function and range of motion more effectively than anti-inflammatory treatment alone by addressing both the inflammatory and mechanical components of the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + ketorolac.